首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1900247

生物標記技術市場規模、佔有率和成長分析（按測試類型、產品、分析技術、研究領域、應用和地區分類）—產業預測（2026-2033 年）

Biomarker Technologies Market Size, Share, and Growth Analysis, By Test Type (Solid Biopsy, Liquid Biopsy), By Product, By Profiling Technology, By Research Area, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球生物標記技術市場預計到 2024 年將達到 375.6 億美元，到 2025 年將達到 410.2 億美元，到 2033 年將達到 829.3 億美元，預測期（2026-2033 年）的複合年成長率為 9.2%。

全球生物標記技術市場透過利用生物標記評估正常和異常的生理過程及治療反應，在推動醫療保健發展方面發揮著至關重要的作用。這些生物標記透過聚合酵素鏈鎖反應(PCR)、次世代定序和免疫檢測等先進技術進行識別，從而揭示相關的生物學變化，並在癌症、感染疾病和自體免疫疾病等疾病的診斷中發揮關鍵作用。此外，生物標記還有助於在藥物研發階段早期檢測藥物毒性，從而支持個人化醫療的發展。疾病盛行率的上升、研發活動的增加以及早期毒性檢測的日益普及是推動市場成長的主要因素。然而，高昂的初始投資和較低的認知度等挑戰可能會阻礙市場發展。儘管如此，新興經濟體為未來的市場擴張提供了巨大的機會。

全球生物標記技術市場促進因素

全球生物標記技術市場的主要促進因素之一是癌症、糖尿病和心血管疾病等慢性病盛行率的不斷上升。隨著這些疾病的持續成長，人們對能夠及早識別疾病早期階段的早期精準診斷工具的需求日益成長。生物標記在精準醫療中發揮關鍵作用，能夠實現個人化治療方案，從而提高治療效果並改善患者預後。此外，基因組學和蛋白質組學等技術的進步正在促進新生物標記的發現和檢驗，從而刺激這一快速發展領域的創新和投資。

限制全球生物標記技術市場的因素

全球生物標記技術市場的主要限制因素之一是先進生物標記技術研發和實施的高成本。生物標記發現和檢驗的複雜性以及所需的精密設備，都會給研究機構和醫療組織帶來沉重的經濟負擔。此外，監管機構設置的監管壁壘可能會進一步延緩創新生物標記解決方案的商業化進程，並抑制該領域的投資和探索。這些因素可能導致相關人員採取謹慎態度，從而阻礙市場成長和生物標記技術的廣泛應用。

全球生物標記技術市場趨勢

由於個人化醫療加速融入醫療實踐，全球生物標記技術市場正經歷變革性的轉變。隨著基因組學、蛋白質組學和分子診斷技術的進步，生物標記對於最佳化個別患者的疾病管理以及改進診斷、預後和治療策略至關重要。此外，對非侵入性和微創檢測方法（例如液態生物檢體）的需求顯著成長，這些方法在提高診斷準確性的同時，也減輕了患者的負擔。技術創新與以患者為中心的理念的融合，進一步加速了市場成長，並拓展了生物標記技術的應用範圍。

Thermo Fisher Scientific Inc.（United States）
Bio-Rad Laboratories, Inc.（United States）
Danaher Corporation（United States）
Waters Corporation（United States）
Shimadzu Corporation（Japan）
Siemens Healthineers AG（Germany）
Illumina, Inc.（United States）
PerkinElmer, Inc.（United States）
Abbott Laboratories（United States）
Roche Holding AG（Switzerland）
Merck KGaA（Germany）
Becton, Dickinson and Company（United States）
GE Healthcare（United States）
Bruker Corporation（United States）
Hologic, Inc.（United States）
Myriad Genetics, Inc.（United States）
Bio-Techne Corporation（United States）

結論與建議

簡介目錄

Product Code: SQMIG35H2220

Global Biomarker Technologies Market size was valued at USD 37.56 Billion in 2024 and is poised to grow from USD 41.02 Billion in 2025 to USD 82.93 Billion by 2033, growing at a CAGR of 9.2% during the forecast period (2026-2033).

The global biomarker technologies market is vital for advancing healthcare by leveraging biological markers to evaluate normal and abnormal physiological processes and therapeutic responses. These biomarkers are identified using advanced techniques like polymerase chain reaction, next-generation sequencing, and immunoassays, playing a pivotal role in diagnosing conditions such as cancer, infectious diseases, and autoimmune disorders by highlighting relevant biological changes. Additionally, biomarkers facilitate early drug toxicity detection during development, supporting personalized medicine initiatives. Market growth is driven by rising disease prevalence, intensified research and development efforts, and increased use of early toxicity testing. However, challenges such as high initial investments and limited awareness may impede progress. Still, emerging economies present substantial opportunities for market expansion moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomarker Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomarker Technologies Market Segments Analysis

Global Biomarker Technologies Market is segmented by Test Type, Product, Profiling Technology, Research Area, Application and region. Based on Test Type, the market is segmented into Solid Biopsy and Liquid Biopsy. Based on Product, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on Profiling Technology, the market is segmented into Immunoassay, PCR, Imaging Technologies, Mass Spectrometry, NGS, Chromatography, Cytogenetics and Other Profiling Technologies. Based on Research Area, the market is segmented into Genomics, Proteomics, Metabolomics and Other Research Areas. Based on Application, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biomarker Technologies Market

One of the key market drivers for the global biomarker technologies market is the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders. As these conditions continue to rise, there is a heightened demand for early and accurate diagnostic tools that can identify diseases at their onset. Biomarkers play a crucial role in personalized medicine, enabling tailored therapeutic approaches that enhance treatment efficacy and improve patient outcomes. Furthermore, advancements in technology, such as genomics and proteomics, are facilitating the discovery and validation of new biomarkers, thus propelling innovation and investment in this rapidly evolving sector.

Restraints in the Global Biomarker Technologies Market

One key market restraint for the Global Biomarker Technologies Market is the high cost associated with research and development, as well as the implementation of advanced biomarker technologies. The complexities involved in biomarker discovery, validation, and the required sophisticated equipment can lead to significant financial burdens for research institutions and healthcare organizations. Additionally, the regulatory hurdles imposed by governing bodies can further delay the commercialization of innovative biomarker solutions, discouraging investment and exploration in this field. These factors contribute to a cautious approach from stakeholders, potentially hindering market growth and the widespread adoption of biomarker technologies.

Market Trends of the Global Biomarker Technologies Market

The global biomarker technologies market is witnessing a transformative shift, propelled by the increasing integration of personalized medicine into healthcare practices. As the understanding of genomics, proteomics, and molecular diagnostics advances, biomarkers are pivotal in tailoring disease management to individual patients, enhancing the precision of diagnosis, prognosis, and treatment strategies. Furthermore, there is a notable rise in the demand for non-invasive and minimally invasive testing methods, such as liquid biopsies, which are enhancing patient comfort while improving diagnostic accuracy. This convergence of innovation and patient-centric approaches is further fueling market growth and expanding the application scope of biomarker technologies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement

Global Biomarker Technologies Market Size by Test Type & CAGR (2026-2033)

Market Overview
Solid Biopsy
Liquid Biopsy

Global Biomarker Technologies Market Size by Product & CAGR (2026-2033)

Market Overview
Biomarker Identification, Validation & Development Research
- Consumables
- Instruments
- Services
- Software
Routine Biomarker-based tests
- Consumables
- Instruments
- Services
- Software

Global Biomarker Technologies Market Size by Profiling Technology & CAGR (2026-2033)

Market Overview
Immunoassay
- ELISA
- Western Blot
- Protein Microarray
PCR
Imaging Technologies
Mass Spectrometry
NGS
Chromatography
Cytogenetics
Other Profiling Technologies

Global Biomarker Technologies Market Size by Research Area & CAGR (2026-2033)

Market Overview
Genomics
Proteomics
Metabolomics
- Metabolic Flux
- Lipidomics
- Others
Other Research Areas

Global Biomarker Technologies Market Size by Application & CAGR (2026-2033)

Market Overview
Biomarker Identification, Validation & Development Research
Routine Biomarker-based tests

Global Biomarker Technologies Market Size & CAGR (2026-2033)

North America (Test Type, Product, Profiling Technology, Research Area, Application)
- US
- Canada
Europe (Test Type, Product, Profiling Technology, Research Area, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Product, Profiling Technology, Research Area, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Product, Profiling Technology, Research Area, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Product, Profiling Technology, Research Area, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments